Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Pancreatic stellate cells (PSCs) differentiate into cancer-associated fibroblasts (CAFs) that produce desmoplastic stroma, thereby modulating disease progression and therapeutic response in pancreatic ductal adenocarcinoma (PDA). However, it is unknown whether CAFs uniformly carry out these tasks or if subtypes of CAFs with distinct phenotypes in PDA exist. We identified a CAF subpopulation with elevated expression of α-smooth muscle actin (αSMA) located immediately adjacent to neoplastic cells in mouse and human PDA tissue. We recapitulated this finding in co-cultures of murine PSCs and PDA organoids, and demonstrated that organoid-activated CAFs produced desmoplastic stroma. The co-cultures showed cooperative interactions and revealed another distinct subpopulation of CAFs, located more distantly from neoplastic cells, which lacked elevated αSMA expression and instead secreted IL6 and additional inflammatory mediators. These findings were corroborated in mouse and human PDA tissue, providing direct evidence for CAF heterogeneity in PDA tumor biology with implications for disease etiology and therapeutic development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, TGF-β influences CAF expression of cytokines and chemokines that act on cancer, endothelial and/or immune cells, such as HGF245, VEGF, IL-6, IL-8, MCP1, PGE2 and CXCL12229,257–262.”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [229]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In pancreatic cancer, CAFs most proximal to the cancer cells exhibit a myoCAF phenotype, with high TGFβ-driven αSMA expression and a contractile phenotype33.”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [33]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“With respect to CAFs and pancreatic cancer, it has been established that coculture of murine PSCs and PDAC tumor organoids leads to CAF differentiation into two subtypes -one with elevated expression of α -SMA (myo fi broblast-like CAFs) and the other with high expression of IL-6 (in fl ammatory CAFs) [61].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [61]
The cited source says what the claim attributes to it.
In the citing paper
“CAFs that are in close proximity to cancer cells present a myo fi broblast-like phenotype (myCAF) de fi ned by a high expression of α -SMA”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [61]
The cited source says what the claim attributes to it.
In the citing paper
“whereas CAFs distant from cancer cells barely express α -SMA but secrete high amounts of in fl ammatory cytokine IL-6 (iCAF)”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [61]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Differential expression analysis for sequence count data
Anders, S., & Huber, W. (2010) · Genome Biology · doi:10.1186/gb-2010-11-10-r106 · Cited by 15,581
Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Self-citationCre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Self-citation
Cited by
Items 901–1,000 of 1,008
Colvin, E. K., Howell, V. M., Mok, S. C., Samimi, G., & Vafaee, F. (2020) · Cancer Science · doi:10.1111/cas.14350 · Cited by 34
Ohara, Y., Enomoto, A., Tsuyuki, Y., Sato, K., Iida, T., Kobayashi, H., Mizutani, Y., Miyai, Y., Hara, A., Mii, S., et al. (2020) · Oncology Reports · doi:10.3892/or.2020.7669 · Cited by 38
Malchiodi, Z. X., & Weiner, L. M. (2021) · Cancers · doi:10.3390/cancers13030405 · Cited by 37
Organoids in cancer research: a review for pathologist‐scientists
Wood, L. D., & Ewald, A. J. (2021) · The Journal of Pathology · doi:10.1002/path.5684 · Cited by 38
Remodeling tumor microenvironment with nanomedicines
Martin, J. D., Miyazaki, T., & Cabral, H. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1730 · Cited by 42
Romanò, R., Picca, A., Eusebi, L. H., Marzetti, E., Calvani, R., Moro, L., Bucci, C., & Guerra, F. (2021) · Cells · doi:10.3390/cells10061361 · Cited by 39
Farhat, J., Pandey, I., & Alwahsh, M. (2021) · Cells · doi:10.3390/cells10071657 · Cited by 36
Interactions with stromal cells promote a more oxidized cancer cell redox state in pancreatic tumors
Datta, R., Sivanand, S., Lau, A. N., Florek, L., Barbeau, A. M., Wyckoff, J. B., Skala, M. C., & Heiden, M. G. V. (2022) · Science Advances · doi:10.1126/sciadv.abg6383 · Cited by 37
Halperin, C., Hey, J., Weichenhan, D., Stein, Y., Mayer, S., Lutsik, P., Plass, C., & Scherz‐Shouval, R. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0209 · Cited by 36
Shi, X., Wang, M., Zhang, Y., Guo, X., Liu, M., Zhou, Z., Zhao, Y., He, R., Gao, Y., Liu, Y., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104352 · Cited by 38
Zhao, H., Li, R., Chen, Y., Yang, X. Y., & Shang, Z. (2023) · Oncogene · doi:10.1038/s41388-023-02642-5 · Cited by 38
Cancer-Associated Fibroblasts in Pancreatic Cancer: Should They Be Deleted or Reeducated?
Qu, C., Wang, Q., Meng, Z., & Wang, P. (2018) · Integrative Cancer Therapies · doi:10.1177/1534735418794884 · Cited by 34
Connecting the Human Microbiome and Pancreatic Cancer
Sexton, R. E., Uddin, M. H., Bannoura, S. F., Khan, H. Y., Mzannar, Y., Li, Y., Aboukameel, A., Al-Hallak, M. N., Al-Share, B. A., Mohamed, A., et al. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10022-w · Cited by 38
Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
Skorupan, N., Domínguez, M. P., Ricci, S. L., & Alewine, C. (2022) · Cancers · doi:10.3390/cancers14174209 · Cited by 38
Huang, Q., Chen, H., Yin, D., Wang, J., Wang, S., Feng, Y., Li, J., Mu, T., Li, J., Zhao, J., et al. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00509-w · Cited by 37
The Role of Nrf2 in the Regulation of Mitochondrial Function and Ferroptosis in Pancreatic Cancer
Baiskhanova, D. M., & Schäfer, H. (2024) · Antioxidants · doi:10.3390/antiox13060696 · Cited by 44
Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
Lv, K., & He, T. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00233-8 · Cited by 42
Cangkrama, M., Liu, H., Wu, X. O., Yates, J., Whipman, J., Gäbelein, C. G., Matsushita, M., Ferrarese, L., Sander, S., Castro-Giner, F., et al. (2025) · Nature Cancer · doi:10.1038/s43018-025-01038-6 · Cited by 53
Baker, L. A., Tiriac, H., & Tuveson, D. A. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8879-2_9 · Cited by 35
Self-citationMaehira, H., Miyake, T., Iida, H., Tokuda, A., Mori, H., Yasukawa, D., Mukaisho, K., Shimizu, T., & Tani, M. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07891-x · Cited by 38
Mardhian, D. F., Vrynas, A. V., Storm, G., Bansal, R., & Prakash, J. (2020) · Nanotheranostics · doi:10.7150/ntno.38092 · Cited by 35
Biomimetic stiffening of cell-laden hydrogels via sequential thiol-ene and hydrazone click reactions
Chang, C., Johnson, H. C., Babb, O., Fishel, M. L., & Lin, C. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.05.054 · Cited by 35
Activation of STING in the pancreatic tumor microenvironment: A novel therapeutic opportunity
Chamma, H., Vila, I. K., Taffoni, C., Turtoï, A., & Laguette, N. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215694 · Cited by 36
Neoadjuvant therapy alters the immune microenvironment in pancreatic cancer
Zhang, H., Ye, L., Yu, X., Jin, K., & Wu, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.956984 · Cited by 39
Li, X., Zhou, J., Wang, X., Li, C., Ma, Z., Wan, Q., & Fu, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1152312 · Cited by 47
Hanley, C. J., & Thomas, G. J. (2021) · Oncotarget · doi:10.18632/oncotarget.27936 · Cited by 35
Elwakeel, E., Brüggemann, M., Wagih, J., Lityagina, O., Elewa, M. A. F., Han, Y., Frömel, T., Popp, R., Nicolas, A. M., Schreiber, Y., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-2116 · Cited by 32
Cancer‐associated fibroblasts: Is it a key to an intricate lock of tumorigenesis?
Aden, D., Zaheer, S., Ahluwalia, H., & Ranga, S. (2023) · Cell Biology International · doi:10.1002/cbin.12004 · Cited by 33
Chen, H., Fang, S.-P., Zhu, X., & Liu, H. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1412337 · Cited by 35
Ielpo, S., Barberini, F., Moghaddam, F. D., Pesce, S., Cencioni, C., Spallotta, F., Ninno, A. D., Businaro, L., Marcenaro, E., Bei, R., et al. (2024) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2024.102843 · Cited by 36
Iron-loaded cancer-associated fibroblasts induce immunosuppression in prostate cancer
Zhang, K., Liu, K., Hu, B., Du, G., Chen, X., Xiao, L., Zhang, Y., Jiang, L., Jing, N., Cheng, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53233-1 · Cited by 40
Typing of pancreatic cancer-associated fibroblasts identifies different subpopulations
Nielsen, M. F. B., Mortensen, M. B., & Detlefsen, S. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i41.4663 · Cited by 33
Stress responses in stromal cells and tumor homeostasis
Vitale, I., Manic, G., Galassi, C., & Galluzzi, L. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.04.004 · Cited by 34
Pharmacogenetics of treatments for pancreatic cancer
Hassouni, B. E., Petri, G. L., Liu, D., Cascioferro, S., Parrino, B., Hassan, W. U., Diana, P., Ali, A., Frampton, A. E., & Giovannetti, E. (2019) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2019.1620731 · Cited by 34
Agorku, D., Langhammer, A., Heider, U., Wild, S., Bosio, A., & Hardt, O. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00716 · Cited by 40
Bhat, V., Allan, A. L., & Raouf, A. (2019) · Cancers · doi:10.3390/cancers11091240 · Cited by 36
CD36 and CD97 in Pancreatic Cancer versus Other Malignancies
Tănase, C., Gheorghișan-Gălățeanu, A.-A., Popescu, I. D., Mihai, S., Codrici, E., Albulescu, R., & Hinescu, M. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165656 · Cited by 33
Cho, C., Mukherjee, R., Peck, A. R., Sun, Y., McBrearty, N., Katlinski, K. V., Gui, J., Govindaraju, P. K., Puré, E., Rui, H., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01424-7 · Cited by 41
Mirage or long-awaited oasis: reinvigorating T-cell responses in pancreatic cancer
Ware, M. B., El‐Rayes, B. F., & Lesinski, G. B. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001100 · Cited by 34
The Gustatory Sensory G-Protein GNAT3 Suppresses Pancreatic Cancer Progression in Mice
Hoffman, M. T., Kemp, S. B., Salas-Escabillas, D. J., Zhang, Y., Steele, N. G., The, S., Long, D., Benitz, S., Wei, Y., Margolskee, R. F., et al. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.08.011 · Cited by 32
Brennen, W. N., Thorek, D. L. J., Jiang, W., Krueger, T. E. G., Antony, L., Denmeade, S. R., & Isaacs, J. T. (2020) · Immunotherapy · doi:10.2217/imt-2020-0066 · Cited by 35
Amrutkar, M., Vethe, N. T., Verbeke, C. S., Aasrum, M., Finstadsveen, A. V., Sántha, P., & Gladhaug, I. P. (2020) · Cancers · doi:10.3390/cancers12123628 · Cited by 42
AKT3 Is a Novel Regulator of Cancer-Associated Fibroblasts in Head and Neck Squamous Cell Carcinoma
Takahashi, H., Rokudai, S., Kawabata‐Iwakawa, R., Sakakura, K., Oyama, T., Nishiyama, M., & Chikamatsu, K. (2021) · Cancers · doi:10.3390/cancers13061233 · Cited by 36
Yu, S., Lu, Y., Su, A., Chen, J., Li, J., Zhou, B., Liu, X., Xia, Q., Li, Y., Li, J., et al. (2021) · Advanced Science · doi:10.1002/advs.202101848 · Cited by 34
Sunami, Y., Häußler, J., Zourelidis, A. A., & Kleeff, J. H. (2022) · Cancers · doi:10.3390/cancers14030744 · Cited by 38
Modeling the mechanical stiffness of pancreatic ductal adenocarcinoma
Kpeglo, D., Hughes, M. D. G., Dougan, L., Haddrick, M., Knowles, M. A., Evans, S. D., & Peyman, S. A. (2022) · Matrix Biology Plus · doi:10.1016/j.mbplus.2022.100109 · Cited by 40
The Liver Pre-Metastatic Niche in Pancreatic Cancer: A Potential Opportunity for Intervention
Gumberger, P., Björnsson, B., Sandström, P., Bojmar, L., & Zambirinis, C. P. (2022) · Cancers · doi:10.3390/cancers14123028 · Cited by 39
Shinkawa, T., Ohuchida, K., & Nakamura, M. (2022) · Cancers · doi:10.3390/cancers14163994 · Cited by 36
Integrin α11β1 in tumor fibrosis: more than just another cancer-associated fibroblast biomarker?
Zeltz, C., Navab, R., Heljäsvaara, R., Kusche‐Gullberg, M., Lü, N., Tsao, M., & Gullberg, D. (2022) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-022-00673-3 · Cited by 31
The Outside-In Journey of Tissue Transglutaminase in Cancer
Sima, L. E., Matei, D. E., & Condello, S. (2022) · Cells · doi:10.3390/cells11111779 · Cited by 38
Lencioni, G., Gregori, A., Toledo, B., Rebelo, R., Immordino, B., Amrutkar, M., Xavier, C. P. R., Kocijancic, A., Pandey, D. P., Perán, M., et al. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.09.002 · Cited by 35
Disruption of cellular plasticity by repeat RNAs in human pancreatic cancer
You, E., Danaher, P. J., Lu, C., Sun, S., Zou, L. S., Phillips, I. E., Rojas, A. S., Ho, N. I., Song, Y., Raabe, M. J., et al. (2024) · Cell · doi:10.1016/j.cell.2024.09.024 · Cited by 33
You, E., Huh, Y. H., Kwon, A., Kim, S., Chae, I. H., Lee, O.-J., Ryu, J.-H., Park, M. H., Kim, G., Lee, J. S., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0657 · Cited by 30
Gioeli, D., Snow, C. J., Simmers, M. B., Hoang, S. A., Figler, R. A., Allende, J. A., Roller, D. G., Parsons, J. T., Wulfkuhle, J. D., Petricoin, E. F., et al. (2019) · Lab on a Chip · doi:10.1039/c8lc00755a · Cited by 31
Han, X., Zhang, W.-H., Wang, W., Yu, X., & Liu, L. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188444 · Cited by 36
Selvanesan, B. C., Meena, K., Beck, A. P., Meheus, L., Lara, O., Rooman, I., & Gravekamp, C. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001250 · Cited by 34
Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy
Hofschröer, V., Najder, K., Rugi, M., Bouazzi, R., Cozzolino, M., Arcangeli, A., Panyi, G., & Schwab, A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.586599 · Cited by 37
Organoid technology for personalized pancreatic cancer therapy
Bengtsson, A., Andersson, R. E., Rahm, J., Ganganna, K., Andersson, B., & Ansari, D. (2021) · Cellular Oncology · doi:10.1007/s13402-021-00585-1 · Cited by 36
Cancer-Associated Fibroblast Subgroups Showing Differential Promoting Effect on HNSCC Progression
Kang, S. H., Oh, S. Y., Lee, H., Kwon, T., Kim, J., Lee, S., Choi, S., & Hong, S. (2021) · Cancers · doi:10.3390/cancers13040654 · Cited by 32
Tumor Microenvironment in Pancreatic Intraepithelial Neoplasia
Opitz, F. V., Häberle, L., Daum, A., & Esposito, I. (2021) · Cancers · doi:10.3390/cancers13246188 · Cited by 37
3D Cell Models in Radiobiology: Improving the Predictive Value of In Vitro Research
Antonelli, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310620 · Cited by 37
Implications of genetic heterogeneity in hepatocellular cancer
Suresh, A., & Dhanasekaran, R. (2022) · Advances in cancer research · doi:10.1016/bs.acr.2022.01.007 · Cited by 38
Li, Q., Lv, X., Han, C., Kong, Y., Dai, Z., Huo, D., Li, T., Li, D., Li, W., Wang, X., et al. (2022) · Theranostics · doi:10.7150/thno.75853 · Cited by 36
Sun, C., Zhang, K., Chen, N., Wan, J., Duan, X., Lou, X., Yao, X., Li, X., Wang, M., Gu, Z., et al. (2023) · Oncogenesis · doi:10.1038/s41389-023-00463-5 · Cited by 37
Key aspects for conception and construction of co-culture models of tumor-stroma interactions
Mason, J. E., & Öhlund, D. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1150764 · Cited by 32
Self-citationHe, J., Chen, Y., Zeng, F., Huang, Q., Zhang, H., Wang, S., Yu, S.-X., Pang, X., Liu, Y., Xu, X., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02697-y · Cited by 35
Zubal, M., Výmolová, B., Matrasová, I., Výmola, P., Vepřková, J., Syrůček, M., Tomáš, R., Vaníčková, Z., Krepela, E., Konečná, D., et al. (2023) · Pathology · doi:10.1016/j.pathol.2023.05.003 · Cited by 33
Microenvironmental regulation of T-cells in pulmonary hypertension
Plecitá‐Hlavatá, L., Brázdová, A., Křivonosková, M., Hu, C., Phang, T. L., Tauber, J. A., Li, M., Zhang, H., Höetzenecker, K., Crnković, S., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1223122 · Cited by 33
Nanomedicine Strategies for Targeting Tumor Stroma
Su, M., Nethi, S. K., Dhanyamraju, P. K., & Prabha, S. (2023) · Cancers · doi:10.3390/cancers15164145 · Cited by 33
Rebuilding the microenvironment of primary tumors in humans: a focus on stroma
Mun, S., Lee, H. J., & Kim, P. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01191-5 · Cited by 34
Darrigues, E., Nima, Z. A., Nedosekin, D. A., Watanabe, F., Alghazali, K. M., Zharov, V. P., & Biris, A. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-59226-6 · Cited by 33
Xuefeng, X., Hou, M., Yang, Z., Agudamu, A., Wang, F., Su, X., Li, X., Shi, L., Terigele, T., Bao, L., et al. (2020) · Journal of International Medical Research · doi:10.1177/0300060520931242 · Cited by 34
Fibroblast Reprogramming in Gastrointestinal Cancer
Melissari, M., Chalkidi, N., Sarris, M. E., & Koliaraki, V. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00630 · Cited by 32
Amrutkar, M., & Gladhaug, I. P. (2021) · Cancers · doi:10.3390/cancers13040601 · Cited by 33
PGC1α-Mediated Metabolic Reprogramming Drives the Stemness of Pancreatic Precursor Lesions
Nimmakayala, R. K., Rauth, S., Venkata, R. C., Marimuthu, S., Nallasamy, P., Vengoji, R., Lele, S. M., Rachagani, S., Mallya, K. B., Malafa, M. P., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-5020 · Cited by 30
Engineering strategies to capture the biological and biophysical tumor microenvironment in vitro
Tan, M. L., Lu, L., & Fischbach, C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113852 · Cited by 32
ELF3 Mediates IL -1α Induced Differentiation of Mesenchymal Stem Cells to Inflammatory iCAFs
Tran, L. L., Dang, T., Thomas, R., & Rowley, D. R. (2021) · Stem Cells · doi:10.1002/stem.3455 · Cited by 30
Immunobiology of cancer-associated fibroblasts in the context of radiotherapy
Hellevik, T., Berzaghi, R., Lode, K., Islam, A., & Martínez-Zubiaurre, I. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03112-w · Cited by 33
Cancer-Homing CAR-T Cells and Endogenous Immune Population Dynamics
Guerra, E., Pietro, R. D., Basile, M., Trerotola, M., & Alberti, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010405 · Cited by 32
Potential Therapeutic Applications of N-Cadherin Antagonists and Agonists
Blaschuk, O. W. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.866200 · Cited by 32
Hu, F., Li, Y., Zhang, L., Ji, D., Liu, X.-Z., Chen, Y., Wang, L., & Wu, A. (2023) · Communications Biology · doi:10.1038/s42003-023-04441-w · Cited by 35
Deciphering cancer fibroblasts
Biffi, G., & Tuveson, D. A. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20182069 · Cited by 35
Self-citationInhibiting stromal Class I HDACs curbs pancreatic cancer progression
Liang, G., Oh, T. G., Hah, N., Tiriac, H., Shi, Y., Truitt, M., Antal, C. E., Atkins, A. R., Li, Y., Fraser, C. R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42178-6 · Cited by 35
Self-citationToward reproducible tumor organoid culture: focusing on primary liver cancer
Guo, L., Li, C., & Gong, W. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1290504 · Cited by 38
Gou, Z., Li, J., Liu, J., & Yang, N. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1378302 · Cited by 38
Rauth, S., Malafa, M. P., Ponnusamy, M. P., & Batra, S. K. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.05.005 · Cited by 34
Menche, C., Schuhwerk, H., Armstark, I., Gupta, P., Fuchs, K., van Roey, R., Mosa, M. H., Hartebrodt, A., Hajjaj, Y., Ezquerra, A. C., et al. (2024) · EMBO Reports · doi:10.1038/s44319-024-00186-7 · Cited by 35
Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges
Cigliano, A., Liao, W., Deiana, G. A., Rizzo, D., Chen, X., & Calvisi, D. F. (2024) · Biomedicines · doi:10.3390/biomedicines12071624 · Cited by 41
Tao, J., Gu, Y., Zhang, Z., Weng, G., Liu, Y., Ren, J., Shi, Y., Qiu, J., Wang, Y., Su, D., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03201-w · Cited by 32
Oszvald, Á., Szvicsek, Z., Pápai, M., Kelemen, A., Varga, Z., Tölgyes, T., Dede, K., Bursics, A., Buzás, E. I., & Wiener, Z. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00558 · Cited by 32
Gatti, F., Mia, S., Hammarström, C. L., Frerker, N., Fosby, B., Wang, J., Pietka, W., Sundnes, O., Fosse, J. H., Kasprzycka, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-80509-5 · Cited by 30
Martínez‐Useros, J., Martin-Galan, M., & García‐Foncillas, J. (2021) · Cancers · doi:10.3390/cancers13020322 · Cited by 30
Dichotomous and stable gamma delta T-cell number and function in healthy individuals
Ou, L., Wang, H., Liu, Q., Zhang, J., Lu, H., Luo, L., Shi, C., Lin, S., Dong, L., Guo, Y., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-002274 · Cited by 36
Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment
Muñoz, R., Girotti, A., Hileeto, D., & Arias, F. J. (2021) · Cancers · doi:10.3390/cancers13215414 · Cited by 34
Hayasaka, H., Yoshida, J., Kuroda, Y., Nishiguchi, A., Matsusaki, M., Kishimoto, K., Nishimura, H., Okada, M., Shimomura, Y., Kobayashi, D., et al. (2022) · Cancer Science · doi:10.1111/cas.15293 · Cited by 33
Ando, R., Sakai, A., Iida, T., Kataoka, K., Mizutani, Y., & Enomoto, A. (2022) · Cancers · doi:10.3390/cancers14143315 · Cited by 33
Tumor microenvironment in pancreatic ductal adenocarcinoma: Implications in immunotherapy
Smith, C., Zheng, W., Dong, J., Wang, Y., Lai, J., Liu, X., & Yin, F. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i27.3297 · Cited by 31
IL-1RAP, a Key Therapeutic Target in Cancer
Frenay, J., Bellaye, P., Oudot, A., Helbling, A., Petitot, C., Ferrand, C., Collin, B., & Dias, A. M. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314918 · Cited by 30
Hajiabadi, S., Alidadi, S., Farahi, Z. M., Seno, M. M. G., Farzin, H., & Haghparast, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1258691 · Cited by 31
Emerging roles of 3D-culture systems in tackling tumor drug resistance
Nikdouz, A., & Orso, F. (2023) · Cancer Drug Resistance · doi:10.20517/cdr.2023.93 · Cited by 33
Metadata
- Authors
- Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., Chio, I. I. C., Hwang, C.-I., Tiriac, H., Baker, L. A., Engle, D. D., Feig, C., Kultti, A., Egeblad, M., Fearon, D. T., Crawford, J. M., Clevers, H., Park, Y., & Tuveson, D. A.
- Affiliations
- Cold Spring Harbor Laboratory (US)
- Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724 1
- University of Verona (IT)
- University of Cambridge (GB)
- Hofstra University (US)
- Royal Netherlands Academy of Arts and Sciences (NL)
- ORCID
- Öhlund, Daniel
- Biffi, Giulia
- Almeida, Ana S.
- Corbo, Vincenzo
- Oni, Tobiloba E.
- Hearn, Stephen A.
- Lee, Eun Jung
- Chio, Iok In Christine
- Hwang, Chang-Il
- Tiriac, Hervé
- Baker, Lindsey A.
- Engle, Dannielle D.
- Feig, Christine
- Kultti, Anne
- Egeblad, Mikala
- Fearon, Douglas T.
- Crawford, James M.
- Clevers, Hans
- Park, Youngkyu
- Tuveson, David A.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2017-02-23
- Volume
- 214
- Issue
- 3
- Pages
- 579-596
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC5339682
- OpenAlex
- W2590390825
- Cited by
- 2,590
- References
- 58
- Citations by year
- 2026: 349 · 2025: 333 · 2024: 350 · 2023: 343 · 2022: 335 · 2021: 349 · 2020: 260 · 2019: 144 · 2018: 89 · 2017: 36
- FWCI
- 64.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (publishedVersion, other-oa)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Cork Open Research Archive (University College Cork, Ireland) (acceptedVersion, cc-by)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- Lustgarten Foundation
- National Institutes of Health (5P30CA45508-26, 5P50CA101955-07, 1U10CA180944-02, 5U01CA168409-5, 1R01CA188134, 1R01CA190092-03, R50CA311506-01, CA101955 UAB/UMN SPORE, 5T32CA148056, F32CA192904)
- Stand Up to Cancer
- STARR foundation (I7-A718)
- DOD (W81XWH-13-PRCRP-IA)
- Swedish Research Council (537-2013-7277)
- Kempe Foundations (JCK-1301)
- Swedish Society of Medicine (SLS-326921, SLS-250831, SLS-175991, SLS-591551)
- Cancer Research Foundation in Northern Sweden (AMP15-793, LP11-1927)
- Human Frontiers Science Program (LT000403/2014, LT000195/2015-L, LT000190/2013)
- Weizmann Institute of Science
- EMBO (ALTF 1203-2014)
- Italian Ministry of Health (FIRB - RBAP10AHJ)
- Associazione Italiana Ricerca Cancro (18718)
- Damon Runyon Cancer Research Foundation (DRG-2165-13)
- National Cancer Institute (1K99CA204725-01A1)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- pancreatic ductal adenocarcinoma, cancer-associated fibroblasts, CAF heterogeneity, pancreatic stellate cells, myofibroblasts, desmoplastic stroma, alpha-smooth muscle actin, interleukin-6, tumor microenvironment, organoid co-culture, tumor-fibroblast interaction
- MeSH terms
- Actins, Animals, Cells, Cultured, Fibroblasts, Humans, Mice, Inbred C57BL, Pancreatic Neoplasms, Cytokines, Carcinoma, Pancreatic Ductal, STAT3 Transcription Factor, Mice, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.